Lebwohl, Mark G, Jeffrey Sugarman, David M Pariser, Jerry Bagel, Cynthia Trickett, Abby Jacobson, and Robert Israel. “Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study”. SKIN The Journal of Cutaneous Medicine 4, no. 5 (September 2, 2020): s38. Accessed July 5, 2022. https://www.jofskin.org/index.php/skin/article/view/987.